ATE253119T1 - Verwendung des glucoamylasepromotors aus apergillus - Google Patents

Verwendung des glucoamylasepromotors aus apergillus

Info

Publication number
ATE253119T1
ATE253119T1 AT96116202T AT96116202T ATE253119T1 AT E253119 T1 ATE253119 T1 AT E253119T1 AT 96116202 T AT96116202 T AT 96116202T AT 96116202 T AT96116202 T AT 96116202T AT E253119 T1 ATE253119 T1 AT E253119T1
Authority
AT
Austria
Prior art keywords
coding regions
expression
foreign
aspergillus
secretion
Prior art date
Application number
AT96116202T
Other languages
English (en)
Inventor
David Ivor Gwynne
Francis Paul Buxton
Mark Hudson Pickett
Roger Wayne Davies
Claudio Scazzocchio
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/811,404 external-priority patent/US5198345A/en
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE253119T1 publication Critical patent/ATE253119T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2422—Alpha-amylase (3.2.1.1.) from plant source
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2428—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01003—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Mushroom Cultivation (AREA)
  • Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Looms (AREA)
  • Treatment Of Sludge (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT96116202T 1985-04-15 1986-04-14 Verwendung des glucoamylasepromotors aus apergillus ATE253119T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA479135 1985-04-15
US06/811,404 US5198345A (en) 1985-04-15 1985-12-20 Vectors in use in filamentous fungi

Publications (1)

Publication Number Publication Date
ATE253119T1 true ATE253119T1 (de) 2003-11-15

Family

ID=25670651

Family Applications (2)

Application Number Title Priority Date Filing Date
AT86902449T ATE161881T1 (de) 1985-04-15 1986-04-14 Verwendung von promotoren von filamentösen pilzen
AT96116202T ATE253119T1 (de) 1985-04-15 1986-04-14 Verwendung des glucoamylasepromotors aus apergillus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT86902449T ATE161881T1 (de) 1985-04-15 1986-04-14 Verwendung von promotoren von filamentösen pilzen

Country Status (6)

Country Link
EP (1) EP0284603B1 (de)
JP (1) JP2868179B2 (de)
AT (2) ATE161881T1 (de)
AU (1) AU606033B2 (de)
DE (2) DE3650783T2 (de)
WO (1) WO1986006097A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8508800D0 (en) * 1985-04-04 1985-05-09 Glaxo Group Ltd Microbiological process
DE3650202T3 (de) * 1985-08-29 2004-06-03 Genencor International, Inc., South San Francisco Expression von heterologen Polypeptiden in filamentösen Pilzen, Verfahren zu deren Herstellung und Vektoren zu deren Herstellung.
US5364770A (en) 1985-08-29 1994-11-15 Genencor International Inc. Heterologous polypeptides expressed in aspergillus
US6004785A (en) * 1985-08-29 1999-12-21 Genencor International Inc. Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same
US4935349A (en) * 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
US5536661A (en) * 1987-03-10 1996-07-16 Novo Nordisk A/S Process for the production of protein products in aspergillus
US5766912A (en) 1986-03-17 1998-06-16 Novo Nordisk A/S Humicola lipase produced in aspergillus
FI872102A7 (fi) * 1986-06-06 1987-12-07 Panlabs Inc Rihmasienten ilmentymisjärjestelmät.
GB8702475D0 (en) 1987-02-04 1987-03-11 Ciba Geigy Ag Expression system
US5447862A (en) * 1987-02-04 1995-09-05 Ciba-Geigy Corporation Pectin lyase genes of aspergillus niger
EP0383779B2 (de) * 1987-09-04 2000-05-31 Novo Nordisk A/S VERFAHREN ZUR HERSTELLUNG VON PROTEINPRODUKTEN IN $i(ASPERGILLUS) UND PROMOTOREN ZUR VERWENDUNG IN $i(ASPERGILLUS)
US5252726A (en) * 1987-09-04 1993-10-12 Novo Nordisk A/S Promoters for use in aspergillus
DE68913846T3 (de) * 1988-07-28 2002-10-02 Novartis Ag, Basel Expressionssystem.
US5162228A (en) * 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
DE69032616T2 (de) * 1989-06-16 1999-03-11 Genencor International, Inc., Rochester, N.Y. Dna-sequenzen, vektoren und fusionspolypeptide zur erhöhung der sekretion gewünschter polypeptide von filamentösen fungi
JP2995770B2 (ja) * 1989-12-15 1999-12-27 吉富製薬株式会社 異種蛋白質の製造方法
AU7493491A (en) * 1990-03-13 1991-10-10 Hawaii Biotechnology Group, Inc. (neurospora) expression system
DE69332607T2 (de) * 1992-03-04 2003-05-08 Genencor International, Inc. Herstellung von -i(aspergillus niger katalase-r)
US5382658A (en) * 1992-04-03 1995-01-17 Allelix Biopharmaceuticals Inc. Stability-enhanced variants of parathyroid hormone
CA2098639A1 (en) * 1992-06-19 1993-12-20 K. Anne Kronis Bone stimulating, non-vasoactive parathyroid hormone variants
DE69332030T2 (de) * 1992-12-10 2002-10-02 Dsm N.V., Heerlen Herstellung von heterologen proteinen in filamentösen fungi
GB9316883D0 (en) * 1993-08-13 1993-09-29 Univ Leeds Production of heterologous peptices
ES2080689B1 (es) * 1994-04-21 1996-09-01 Urquima Sa Procedimiento de obtencion de un edulcorante natural proteico.
GB9515941D0 (en) 1995-08-03 1995-10-04 Zeneca Ltd DNA constructs
ATE256747T1 (de) * 1995-05-18 2004-01-15 Genencor Int Glykosyltransferase expression in aspergillus
GB9907461D0 (en) 1999-03-31 1999-05-26 King S College London Neurite regeneration
US8372620B2 (en) 1998-12-23 2013-02-12 Dupont Nutrition Biosciences Aps Bacterial xylanases
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
ES2394481T3 (es) 2000-09-21 2013-02-01 Basf Se Xilanasa de talaromyces
ATE475324T1 (de) 2000-12-07 2010-08-15 Dsm Ip Assets Bv Mit carboxy-terminal prolin peptide angereicherte proteinhydrolysate
CA2706364A1 (en) 2000-12-07 2002-06-13 Dsm Ip Assets B.V. Method for the prevention or reduction of haze in beverages
GB0116453D0 (en) 2001-07-05 2001-08-29 Imp College Innovations Ltd Method
AU2003228145B2 (en) 2002-06-07 2009-10-08 Dsm Ip Assets B.V. Improved method for the prevention or reduction of haze in beverages
TWI328612B (en) 2002-07-25 2010-08-11 Dsm Ip Assets Bv Genes and their encoded polypeptides involved in the biosynthetic pathway of vitamin b12, vectors and host cells comprising the genes, and process for producing vitamin b12
GB0403864D0 (en) 2004-02-20 2004-03-24 Ucl Ventures Modulator
ES2454167T3 (es) 2005-11-28 2014-04-09 Dsm Ip Assets B.V. Preparación de enzima que produce un sabor puro
GB0600406D0 (en) 2006-01-10 2006-02-15 Univ Bath Crystal
BRPI0807768A2 (pt) 2007-02-20 2014-06-24 Dsm Ip Assests Bv Nova sialidase.
JP2010521188A (ja) 2007-03-22 2010-06-24 ディーエスエム アイピー アセッツ ビー．ブイ． 新規リシルオキシダーゼ
CN101835801B (zh) 2007-08-08 2014-09-10 诺维信生物制药丹麦公司 转铁蛋白变体和偶联物
JP2012516878A (ja) 2009-02-06 2012-07-26 ノボザイムス バイオファーマ デーコー アクティーゼルスカブ 精製プロセス
KR101722961B1 (ko) 2009-02-11 2017-04-04 알부메딕스 에이/에스 알부민 변이체 및 접합체
WO2011101339A2 (en) 2010-02-18 2011-08-25 Dsm Ip Assets B.V. Fermentation broth and filtration filter cake and uses thereof
WO2012007445A1 (en) 2010-07-13 2012-01-19 Dsm Ip Assets B.V. Mutarotase in crystallization
WO2012007446A1 (en) 2010-07-13 2012-01-19 Dsm Ip Assets B.V. Use of a mutarotase in the production of dried powders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1207687A (en) * 1982-07-07 1986-07-15 Alan M. Lambowitz Filamentous fungi functional replicating extrachromosomal element
NO840200L (no) * 1983-01-28 1984-07-30 Cefus Corp Glukoamylase cdna.
NZ207925A (en) * 1983-04-25 1988-05-30 Genentech Inc Yeast expression vehicle consisting of a yeast promoter and signal peptide encoding region linked to a heterologus peptide coding region; expression and culture
EP0136907A3 (de) * 1983-10-03 1986-12-30 Genentech, Inc. Xenogeneisches Expressionskontrollsystem, Verfahren zu dessen Verwendung, dieses enthaltende Expressionsvektoren, mit denselben transformierte Zellen und daraus hergestellte heterolose Proteine
EP0423890A3 (en) * 1984-07-27 1991-07-03 Unilever Nv Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant dna technology
EP0191221A1 (de) * 1984-10-24 1986-08-20 The Regents Of The University Of California Vektoren zur Transformation von Ascomyceten
DE3579788D1 (de) * 1984-11-07 1990-10-25 Antibioticos Sa Cephalosporium acremonium,welches mit einem aminoglycosidresistenz transformiert ist.
DE3650202T3 (de) * 1985-08-29 2004-06-03 Genencor International, Inc., South San Francisco Expression von heterologen Polypeptiden in filamentösen Pilzen, Verfahren zu deren Herstellung und Vektoren zu deren Herstellung.

Also Published As

Publication number Publication date
JPH07163389A (ja) 1995-06-27
JP2868179B2 (ja) 1999-03-10
WO1986006097A1 (en) 1986-10-23
DE3650783T2 (de) 2004-07-15
DE3650783D1 (de) 2003-12-04
EP0284603A1 (de) 1988-10-05
DE3650664T2 (de) 1998-04-16
EP0284603B1 (de) 1998-01-07
AU5698686A (en) 1986-11-05
ATE161881T1 (de) 1998-01-15
AU606033B2 (en) 1991-01-31
DE3650664D1 (de) 1998-02-12

Similar Documents

Publication Publication Date Title
ATE253119T1 (de) Verwendung des glucoamylasepromotors aus apergillus
EP0768383A3 (de) Promotoren von filamentösen Pilzen und deren Verwendung
ATE332378T1 (de) Polypeptide mit phytase wirkung
ES2073571T3 (es) Aplicacion de nuevos fragmentos de adn como secuencia que codifica un peptido señal para la secrecion de proteinas maduras, mediante levaduras recombinantes, cassettes de expresion, levaduras transformadas y procedimiento correspondiente de preparacion de proteinas.
ATE196164T1 (de) Gereinigte scytalidium lacassen und nukleinsäuren dafür kodierend
NO932423L (no) Ekspresjon av rekombinante proteiner i attenuerte bakterier
DE3880739D1 (de) Expression von menschlichem proapolipoprotein a-1.
ES552234A0 (es) Un metodo para producir bacterianamente un polipeptido heteralogo que tiene actividad somatotropinica.
NZ219998A (en) Lysostaphin and its production by genetic engineering methods
IL69469A (en) Polypeptide having human h1-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
NO863806D0 (no) Arab promotorer og fremgangsmaate for fremstilling av polypeptider inkludert cecropiner, ved mikrobiologiske teknikker.
ATE364703T1 (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
SE8702272L (sv) Fibronektinbindande protein samt dess framstaellning
WO1998013478A3 (en) Antifungal proteins, dna coding therefore, and hosts incorporating same
PT574347E (pt) Nova protease fungica
NZ241280A (en) Recombinant iga protease with a modified non-functional c-terminal protein sequence
DK0422217T3 (da) Human, rekombinant, placental ribonucleaseinhibitor og fremgangsmåde til produktion
KR890700663A (ko) 소마토트로핀 암호화 cDNA, 발현 벡터 및 숙주
ES2086374T3 (es) Vectores de expresion de adn recombinante y compuestos de adn que codifican la actividad aciltransferasa de aspergillus.
PT100494A (pt) Vector de expressao dictiostelido e processo de expressao de uma proteina desejada
EP0183272A3 (en) Vector capable of efficient gene expression and utilization of such vector
ATE154392T1 (de) Kalzium-geregelter promotor
RU92004585A (ru) Промотор, днк-последовательность, вектор, клетки, способ экспрессии днк

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0768383

Country of ref document: EP

EELA Cancelled due to lapse of time